Flexibility in crisis: Disaster preparedness in clinical trials

The US Food and Drug Administration (FDA) released guidance in September 2023 on how sponsors should conduct trials during turbulent times, following questions about how trials should be handled during the COVID-19 pandemic. Read along here as our Chief Operating Officer Dave Bowser discusses what this guidance means for CROs and sponsors.